Other OTC Pharmaceuticals - United Kingdom

United Kingdom

Highlights

In the United Kingdom, the revenue generated in the market of Other OTC Pharmaceuticals in 2024 amounts to US$460.20m.
It is projected that this market will experience an annual growth rate of 1.62% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, with a total of US$7.17bn in 2024.
Taking into account the total population figures, the per person revenue in the United Kingdom is US$6.77 in 2024.
The United Kingdom is experiencing a surge in demand for alternative OTC pharmaceuticals due to growing interest in natural remedies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in United Kingdom has been experiencing steady growth in recent years.

Customer preferences: Customers in the United Kingdom have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the increasing awareness of self-care and preventive healthcare, and the availability of a wide range of OTC products for various health conditions. Additionally, the rising healthcare costs and long waiting times for doctor appointments have also contributed to the growing demand for OTC pharmaceuticals.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in United Kingdom is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives to traditional pharmaceuticals. This trend is driven by a desire for more sustainable and eco-friendly options, as well as a growing interest in holistic and alternative medicine.Another trend in the market is the growing popularity of online retail channels for purchasing OTC pharmaceuticals. The convenience of online shopping, coupled with the availability of a wide range of products and competitive prices, has attracted a significant number of consumers to online platforms. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across all industries.

Local special circumstances: The United Kingdom has a well-established healthcare system, with a strong emphasis on self-care and community pharmacy services. Community pharmacies play a vital role in the provision of OTC pharmaceuticals, offering advice and guidance to customers on the appropriate use of these products. This close interaction between pharmacists and consumers has contributed to the growth of the Other OTC Pharmaceuticals market in United Kingdom.Furthermore, the National Health Service (NHS) in the United Kingdom has implemented various initiatives to promote self-care and reduce the burden on primary care services. These initiatives include the provision of self-care information and resources, as well as the endorsement of OTC pharmaceuticals for certain health conditions. This supportive environment has created favorable conditions for the growth of the Other OTC Pharmaceuticals market in United Kingdom.

Underlying macroeconomic factors: The United Kingdom has a stable and developed economy, which has contributed to the growth of the Other OTC Pharmaceuticals market. Increasing disposable incomes, coupled with a growing aging population, have led to higher healthcare spending and increased demand for OTC pharmaceuticals. Additionally, the United Kingdom has a strong regulatory framework for the pharmaceutical industry, ensuring the safety and quality of OTC products, which further boosts consumer confidence in these products.In conclusion, the Other OTC Pharmaceuticals market in United Kingdom is experiencing steady growth due to customer preferences for convenience, natural remedies, and online shopping. The local special circumstances, such as the emphasis on self-care and community pharmacy services, further contribute to this growth. The underlying macroeconomic factors, including increasing disposable incomes and a strong regulatory framework, also play a significant role in driving the market's development.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.